These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 2913308)

  • 21. Mode of binding of methyl acceptor substrates to the adrenaline-synthesizing enzyme phenylethanolamine N-methyltransferase: implications for catalysis.
    Gee CL; Tyndall JD; Grunewald GL; Wu Q; McLeish MJ; Martin JL
    Biochemistry; 2005 Dec; 44(51):16875-85. PubMed ID: 16363801
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cell-Effective Transition-State Analogue of Phenylethanolamine
    Mahmoodi N; Minnow YVT; Harijan RK; Bedard GT; Schramm VL
    Biochemistry; 2023 Aug; 62(15):2257-2268. PubMed ID: 37467463
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transition-State Analogues of Phenylethanolamine
    Mahmoodi N; Harijan RK; Schramm VL
    J Am Chem Soc; 2020 Aug; 142(33):14222-14233. PubMed ID: 32702980
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative molecular field analysis (CoMFA) models of phenylethanolamine N-methyltransferase (PNMT) and the alpha2-adrenoceptor: the development of new, highly selective inhibitors of PNMT.
    Grunewald GL; Caldwell TM; Dahanukar VH; Jalluri RK; Criscione KR
    Bioorg Med Chem Lett; 1999 Feb; 9(3):481-6. PubMed ID: 10091706
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Application of the Goldilocks effect to the design of potent and selective inhibitors of phenylethanolamine N-methyltransferase: balancing pKa and steric effects in the optimization of 3-methyl-1,2,3,4-tetrahydroisoquinoline inhibitors by beta-fluorination.
    Grunewald GL; Seim MR; Lu J; Makboul M; Criscione KR
    J Med Chem; 2006 May; 49(10):2939-52. PubMed ID: 16686536
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fragment-based screening by X-ray crystallography, MS and isothermal titration calorimetry to identify PNMT (phenylethanolamine N-methyltransferase) inhibitors.
    Drinkwater N; Vu H; Lovell KM; Criscione KR; Collins BM; Prisinzano TE; Poulsen SA; McLeish MJ; Grunewald GL; Martin JL
    Biochem J; 2010 Oct; 431(1):51-61. PubMed ID: 20642456
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibitors of phenylethanolamine N-methyltransferase that are predicted to penetrate the blood-brain barrier: design, synthesis, and evaluation of 3-fluoromethyl-7-(N-substituted aminosulfonyl)-1,2,3,4-tetrahydroisoquinolines that possess low affinity toward the alpha2-adrenoceptor.
    Romero FA; Vodonick SM; Criscione KR; McLeish MJ; Grunewald GL
    J Med Chem; 2004 Aug; 47(18):4483-93. PubMed ID: 15317460
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Enzyme adaptation to inhibitor binding: a cryptic binding site in phenylethanolamine N-methyltransferase.
    Gee CL; Drinkwater N; Tyndall JD; Grunewald GL; Wu Q; McLeish MJ; Martin JL
    J Med Chem; 2007 Oct; 50(20):4845-53. PubMed ID: 17845018
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Importance of the aromatic ring in adrenergic amines. 7. Comparison of the stereoselectivity of norepinephrine N-methyltransferase for aromatic vs. nonaromatic substrates and inhibitors.
    Rafferty MF; Wilson DS; Monn JA; Krass P; Borchardt RT; Grunewald GL
    J Med Chem; 1982 Oct; 25(10):1198-204. PubMed ID: 7143356
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pre- and postsynaptic effects of SKF64139, a phenylethanolamine N-methyltransferase inhibitor, in conscious normotensive rats.
    Waeber B; Brunner HR; Haeusler G; Gavras H
    J Cardiovasc Pharmacol; 1982; 4(5):759-64. PubMed ID: 6182406
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Conformational preferences of amphetamine analogues for inhibition of phenylethanolamine N-methyltransferase. Conformationally defined adrenergic agents. 5.
    Grunewald GL; Borchardt RT; Rafferty MF; Krass P
    Mol Pharmacol; 1981 Sep; 20(2):377-81. PubMed ID: 7300818
    [No Abstract]   [Full Text] [Related]  

  • 32. The remarkable substrate activity for phenylethanolamine N-methyltransferase of some conformationally defined phenylethylamines lacking a side-chain hydroxyl group. Conformationally defined adrenergic agents. 6.
    Rafferty MF; Grunewald GL
    Mol Pharmacol; 1982 Jul; 22(1):127-32. PubMed ID: 7121446
    [No Abstract]   [Full Text] [Related]  

  • 33. Importance of the aromatic ring in adrenergic amines. 8. 2-(Aminomethyl)-trans-2-decalols as inhibitors of norepinephrine N-methyltransferase.
    Rafferty MF; Krass P; Borchardt RT; Grunewald GL
    J Med Chem; 1982 Oct; 25(10):1250-2. PubMed ID: 7143367
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 1,3-Dimethyl-7-substituted-1,2,3,4-tetrahydroisoquinolines as probes for the binding orientation of tetrahydroisoquinoline at the active site of phenylethanolamine N-methyltransferase.
    Grunewald GL; Caldwell TM; Li Q; Criscione KR
    Bioorg Med Chem; 1999 May; 7(5):869-80. PubMed ID: 10400340
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nanomolar inhibitors of CNS epinephrine biosynthesis: (R)-(+)-3-fluoromethyl-7-(N-substituted aminosulfonyl)-1,2,3,4-tetrahydroisoquinolines as potent and highly selective inhibitors of phenylethanolamine N-methyltransferase1.
    Grunewald GL; Romero FA; Criscione KR
    J Med Chem; 2005 Mar; 48(6):1806-12. PubMed ID: 15771426
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 3-hydroxymethyl-7-(N-substituted aminosulfonyl)-1,2,3,4-tetrahydroisoquinoline inhibitors of phenylethanolamine N-methyltransferase that display remarkable potency and selectivity.
    Grunewald GL; Romero FA; Criscione KR
    J Med Chem; 2005 Jan; 48(1):134-40. PubMed ID: 15634007
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phenylethanolamine N-methyltransferase inhibition: re-evaluation of kinetic data.
    Wu Q; Criscione KR; Grunewald GL; McLeish MJ
    Bioorg Med Chem Lett; 2004 Aug; 14(16):4217-20. PubMed ID: 15261273
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Exploring the active site of phenylethanolamine N-methyltransferase with 3-hydroxyethyl- and 3-hydroxypropyl-7-substituted-1,2,3,4-tetrahydroisoquinolines.
    Grunewald GL; Romero FA; Seim MR; Criscione KR; Deupree JD; Spackman CC; Bylund DB
    Bioorg Med Chem Lett; 2005 Feb; 15(4):1143-7. PubMed ID: 15686930
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibitors of phenylethanolamine N-methyltransferase devoid of alpha2-adrenoceptor affinity.
    Grunewald GL; Lu J; Criscione KR; Okoro CO
    Bioorg Med Chem Lett; 2005 Dec; 15(23):5319-23. PubMed ID: 16169723
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Potential inhibitors of S-adenosylmethionine-dependent methyltransferases. 10. Base- and amino acid modified analogues of S-aristeromycinyl-L-homocysteine.
    Houston DM; Matuszewska B; Borchardt RT
    J Med Chem; 1985 Apr; 28(4):478-82. PubMed ID: 3981540
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.